Skip to main content

Table 1 Baseline characteristics

From: Heart rate recovery and blood pressure response during exercise testing in patients with microvascular angina

  Control (n = 779) MVA (n = 191) p-value
Age, years 52.0 ± 10.9 57.7 ± 9.1 <  0.001
Female gender, n (%) 440 (56.5) 132 (69.1) 0.001
Body mass index, kg/m2 23.3 ± 6.0 24.0 ± 6.6 0.221
Systolic BP, mmHg 127.1 ± 18.4 129.1 ± 16.6 0.262
Diastolic BP, mmHg 78.8 ± 12.6 78.0 ± 12.4 0.514
Smoking, n (%) 133 (25.5) 24 (17.9) 0.070
Alcohol, n (%) 179 (34.4) 30 (22.4) 0.009
Hypertension, n (%) 141 (26.7) 57 (37.3) 0.019
Diabetes mellitus, n (%) 80 (14.4) 27 (19.7) 0.146
Dyslipidemia, n (%) 212 (40.1) 69 (51.9) 0.018
Hyperthyroidism, n (%) 51 (9.6) 9 (6.8) 0.510
Medication
 Aspirin, n (%) 117 (15.0) 34 (17.8) 0.422
 RAS blocker, n (%) 91 (11.7) 33 (17.3) 0.110
 Beta blocker, n (%) 69 (8.9) 25 (13.1) 0.141
 Calcium channel blocker, n (%) 97 (12.5) 31 (16.2) 0.314
 Diuretics, n (%) 21 (2.7) 6 (3.1) 0.769
 Nitrates, n (%) 79 (10.1) 17 (8.9) 0.871
 Statin, n (%) 83 (10.7) 22 (11.5) 0.218
  1. Data are presented as mean ± SD or frequency with percentage in parenthesis. MVA microvascular angina, BP blood pressure, RAS renin-angiotensin system